Relation Between Paradoxical Decrease in High-Density Lipoprotein Cholesterol Levels After Statin Therapy and Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Relation Between Paradoxical Decrease in High-Density Lipoprotein Cholesterol Levels After Statin Therapy and Adverse Cardiovascular Events in Patients With Acute Myocardial Infarction

Published:2015-02 Issue:4 Volume:115 Page:411-416
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Ota Tomoyuki,Ishii Hideki,Suzuki Susumu,Tanaka Akihito,Shibata Yohei,Tatami Yosuke,Harata Shingo,Shimbo Yusaku,Takayama Yohei,Kawamura Yoshihiro,Osugi Naohiro,Maeda Kengo,Kondo Takahisa,Murohara Toyoaki

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Prevalence of coronary heart disease in the Framingham Offspring Study: role of lipoprotein cholesterols;Wilson;Am J Cardiol,1980

2. Major lipids, apolipoproteins, and risk of vascular disease;Di Angelantonio;JAMA,2009

3. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies;Gordon;Circulation,1989

4. High density lipoprotein cholesterol and mortality. The Framingham Heart Study;Wilson;Arteriosclerosis,1988

5. The Residual Risk Reduction Initiative: a call to action to reduce residual vascular risk in patients with dyslipidemia;Fruchart;Am J Cardiol,2008

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An association of ABCG8: rs11887534 polymorphism and HDL-cholesterol response to statin treatment in the Polish population;Pharmacological Reports;2021-06-26

2. Association Between an Acute, Drug-Induced Decrease in High-Density Lipoprotein Cholesterol Levels and Risk of Cardiovascular Events;Clinical Drug Investigation;2020-06-18

3. Long-term statin use before primary percutaneous coronary intervention improves treatment outcomes of acute myocardial infarction;Experimental and Therapeutic Medicine;2017-02-22

4. Impact of Paradoxical Decrease in High-density Lipoprotein Cholesterol Levels After Statin Therapy on Major Adverse Cardiovascular Events in Patients with Stable Angina Pectoris;Clinical Therapeutics;2017-02

5. The Changing Face of HDL and the Best Way to Measure It;Clinical Chemistry;2017-01-01